chalcone has been researched along with Parkinsonian Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Li, Y; Nel, D; Sun, B; Wu, J; Xu, M; Yang, X; Zhang, P | 1 |
| Fu, F; Han, B; Qi, GJ; Wang, L; Wang, T; Wang, Z; Zhang, L | 1 |
| Fu, F; Han, B; Li, C; Li, J; Lv, Y; Wang, L; Wang, S; Wang, T; Wang, Z | 1 |
3 other study(ies) available for chalcone and Parkinsonian Disorders
| Article | Year |
|---|---|
Protective effect of hydroxysafflor yellow A on dopaminergic neurons against 6-hydroxydopamine, activating anti-apoptotic and anti-neuroinflammatory pathways.
Topics: Animals; Apoptosis; Chalcone; Corpus Striatum; Dopamine; Dopaminergic Neurons; Dose-Response Relationship, Drug; Inflammation; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Quinones; Signal Transduction | 2020 |
Hydroxysafflor yellow A promotes α-synuclein clearance via regulating autophagy in rotenone-induced Parkinson's disease mice.
Topics: alpha-Synuclein; Animals; Autophagy; Brain; Chalcone; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Parkinsonian Disorders; Quinones; Rotenone; Uncoupling Agents | 2018 |
Hydroxysafflor Yellow A Improves Motor Dysfunction in the Rotenone-Induced Mice Model of Parkinson's Disease.
Topics: Animals; Chalcone; Dopamine; Male; Mice; Mice, Inbred C57BL; Motor Skills Disorders; Parkinsonian Disorders; Pigments, Biological; Quinones; Random Allocation; Rotarod Performance Test; Rotenone | 2017 |